Clinical Trial Update: Phase 3 Triiodothyronine Supplementation for Infants After Cardiopulmonary Bypass [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating triiodothyronine supplementation after cardiopulmonary bypass in infants with congenital heart defects has completed and results are …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Heart Defects

Drugs mentioned

• Triiodothyronine supplementation (triiodothyronine)

Snippet

Sponsor: Seattle Children's Hospital | Conditions: Congenital Heart Defects | Phase 3 | Status: COMPLETED | Results posted: 2024-04-09